Interstitial lung disease recurrence on chemotherapy rechallenge in breast cancer: a nationwide Japanese database
A notable ILD recurrence rate was observed in breast cancer patients after a cancer-directed therapy rechallenge, highlighting the need for cautious treatment planning and personalised strategies to balance cancer control while mitigating ILD risk.
Authors
- Keiko Sato (ORCID: https://orcid.org/0000-0003-3302-022X)
- Tomohiro Onoue (ORCID: https://orcid.org/0000-0002-3046-5015)
- Wataru Hashimoto (ORCID: https://orcid.org/0000-0003-0185-2371)
- Mayumi Shikano
- Soichiro Nishijima (ORCID: https://orcid.org/0009-0003-7079-2883)
Institutions
- Tokyo University of Science (JP)
- Daiichi Sankyo (Germany) (DE)
- Third Way (US)
- Daiichi-Sankyo (Japan) (JP)
- Daiichi-Sankyo (South Korea) (KR)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1080/14796694.2025.2495543
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Daiichi-Sankyo